Baimukanova Gyulnar, Miyazawa Byron, Potter Daniel R, Muench Marcus O, Bruhn Roberta, Gibb Stuart L, Spinella Philip C, Cap Andrew P, Cohen Mitchell J, Pati Shibani
Blood Systems Research Institute, San Francisco, California.
Department of Surgery, University of California at San Francisco, San Francisco, California.
Transfusion. 2016 Mar;56 Suppl 1(Suppl 1):S65-75. doi: 10.1111/trf.13532.
In current blood banking practices, platelets (PLTs) are stored in plasma at 22°C, with gentle agitation for up to 5 days. To date, the effects of storage and donor variability on PLT regulation of vascular integrity are not known.
In this study, we examined the donor variability of leukoreduced fresh (Day 1) or stored (Day 5) PLTs on vascular endothelial barrier function in vitro and in vivo. In vitro, PLT effects on endothelial cell (EC) monolayer permeability were assessed by analyzing transendothelial electrical resistances (TEER). PLT aggregation, a measure of hemostatic potential, was analyzed by impedance aggregometry. In vivo, PLTs were investigated in a vascular endothelial growth factor A (VEGF-A)-induced vascular permeability model in NSG mice, and PLT circulation was measured by flow cytometry.
Treatment of endothelial monolayers with fresh Day 1 PLTs resulted in an increase in EC barrier resistance and decreased permeability in a dose-dependent manner. Subsequent treatment of EC monolayers with Day 5 PLTs demonstrated diminished vasculoprotective effects. Donor variability was noted in all measures of PLT function. Day 1 PLT donors were more variable in their effects on TEER than Day 5 PLTs. In mice, while all PLTs regardless of storage time demonstrated significant protection against VEGF-A-induced vascular leakage, Day 5 PLTs exhibited reduced protection when compared to Day 1 PLTs. Day 1 PLTs demonstrated significant donor variability against VEGF-A-challenged vascular leakage in vivo. Systemic circulating levels of Day 1 PLTs were higher than those of Day 5 PLTs
In vitro and in vivo, Day 1 PLTs are protective in measures of vascular endothelial permeability. Donor variability is most prominent in Day 1 PLTs. A decrease in the protective effects is found with storage of the PLT units between Day 1 and Day 5 at 22°C, thereby suggesting that Day 5 PLTs are diminished in their ability to attenuate vascular endothelial permeability.
在当前的血液储存实践中,血小板(PLTs)于22°C下在血浆中储存,并轻轻振荡长达5天。迄今为止,储存和供体变异性对血小板调节血管完整性的影响尚不清楚。
在本研究中,我们检测了白细胞滤除的新鲜(第1天)或储存(第5天)血小板对体外和体内血管内皮屏障功能的供体变异性。在体外,通过分析跨内皮电阻(TEER)评估血小板对内皮细胞(EC)单层通透性的影响。通过阻抗聚集法分析血小板聚集,这是一种止血潜力的测量方法。在体内,在NSG小鼠的血管内皮生长因子A(VEGF-A)诱导的血管通透性模型中研究血小板,并通过流式细胞术测量血小板循环。
用第1天新鲜血小板处理内皮单层导致EC屏障电阻增加,并以剂量依赖方式降低通透性。随后用第5天血小板处理EC单层显示血管保护作用减弱。在血小板功能的所有测量中均注意到供体变异性。第1天血小板供体对TEER的影响比第5天血小板更具变异性。在小鼠中,尽管所有血小板无论储存时间如何都对VEGF-A诱导的血管渗漏表现出显著保护作用,但与第1天血小板相比,第5天血小板的保护作用降低。第1天血小板在体内对VEGF-A激发的血管渗漏表现出显著的供体变异性。第1天血小板的全身循环水平高于第5天血小板。
在体外和体内,第1天血小板在血管内皮通透性测量中具有保护作用。供体变异性在第1天血小板中最为突出。在22°C下将血小板单位从第1天储存到第5天,其保护作用降低,从而表明第5天血小板减弱血管内皮通透性的能力降低。